Results 201 to 210 of about 60,263 (313)

Outcomes after treatment with proton pump inhibitors in patients with ineffective esophageal motility: a systematic review. [PDF]

Gastroenterol Hepatol Bed Bench
Sakr F, Soheilipour M, Maghool F, Tabesh E, Bor S, Adibi P.   +5 more
europepmc   +1 more source

Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype

ACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Juvenile dermatomyositis (JDM) is a rare childhood inflammatory myopathy, whereas spondyloarthritis (SpA) is an inflammatory arthropathy characterized by enthesitis and peripheral or axial involvement. We describe a series of patients diagnosed with JDM in childhood who later fulfilled classification criteria for SpA, a sequential phenotype ...
Austen Grooms, Ioannis Karageorgiou, Kerry Mychaliska, James Birmingham   +3 more
wiley   +1 more source

Long-term outcomes of surveillance or endoscopic therapy for low-grade dysplastic Barrett's according to a selective management algorithm. [PDF]

Endosc Int Open
He T, Lai M, Iyer KG, Vogrin S, Slavin JL, Tsoi EH, Holt B, Desmond P, Taylor AC.   +8 more
europepmc   +1 more source

Central blood volume in cirrhosis [PDF]

, 1993
Bendtsen, Flemming, Gerbes, Alexander L., Henriksen, Jens H.   +2 more
core   +1 more source

Spatio‐Temporal Proteomic Landscape Reveals Early Warning Signals of Esophageal Squamous Cell Carcinoma Progression

Advanced Science, Volume 13, Issue 16, 18 March 2026.
This study constructs a proteomic atlas of esophageal squamous cell carcinoma (ESCC) progression using esophageal biopsy samples. It identifies moderate dysplasia as the critical turning stage and a seven‐protein panel for early detection. Functionally, GBP6 loss promotes ESCC progression via cell cycle and epithelial‐mesenchymal transition (EMT ...
Xumiao Li, Jie Yuan, Min Gao, Jibin Liu, Qinqin Wang, Yaqi Zhang, Mingtao Cao, Xiaolin Hu, Hui Yang, Jun Li, Chen Li, Xiaoguang Li, Hui Wang   +12 more
wiley   +1 more source

Preoperative Hill's classification as a predictor of postoperative gastroesophageal reflux disease following laparoscopic sleeve gastrectomy: a prospective multicenter study from Egypt. [PDF]

BMC Surg
Semeya AA, Elmokadem E, Hafez RSAA, Siam M, Othman AAA, Abdalgaliel MM.   +5 more
europepmc   +1 more source

Risk Factors for Anastomotic Stricture and Obstructive Symptoms Following Double‐Flap Technique Reconstruction After Proximal Gastrectomy

Annals of Gastroenterological Surgery, Volume 10, Issue 2, Page 483-491, March 2026.
This retrospective study investigated risk factors for anastomotic stricture and obstructive symptoms following double‐flap technique (DFT) reconstruction after proximal gastrectomy. Mucosal detachment, potentially caused by thermal damage, was identified as a significant risk factor for anastomotic stricture, while continuous suturing at the esophago ...
Shinji Kuroda, Yoshihiko Kakiuchi, Satoru Kikuchi, Hajime Kashima, Nobuhiko Kanaya, Shunya Hanzawa, Kenjiro Kumano, Masahiko Nishizaki, Shunsuke Kagawa, Toshiyoshi Fujiwara   +9 more
wiley   +1 more source

Clinical Outcomes and Prognostic Factors of Stereotactic Radiotherapy for Spinal Metastases With Epidural Spinal Cord Compression Grades 1–2

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Objective Investigate the efficacy of stereotactic radiotherapy in patients with metastatic tumors accompanied by epidural spinal cord compression (ESCC) of Grades 1–2 but without vertebral instability who did not undergo surgery. Methods Based on lesion volume and spinal cord compression degree, SBRT doses of 24 Gy/1f, 30 Gy/3f, and 40 Gy/5f ...
Hongqing Zhuang, Yao Xiao, Jun Li, Yuxia Wang, Cheng Cheng, Liyuan Tao, Feng Wei, Yaqiang Liu   +7 more
wiley   +1 more source

Exploratory Investigation Into Perioperative Treatment Strategies for Potentially Resectable Stage III–N2 Driver Gene–Negative Non–Small Cell Lung Cancer in the Immunotherapy Era

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Comparisons among treatment strategies for potentially resectable Stage III–N2 driver gene–negative non–small cell lung cancer (NSCLC) remain limited. We evaluated three treatment strategies—neoadjuvant chemoimmunotherapy followed by surgery (NCIT+surgery), NCIT followed by chemoradiotherapy (NCIT+CRT), and definitive concurrent ...
Jiarui Zhao, Baiyang Huang, Min Li, Xingpeng Wang, Jingyu Zhu, Kaiyue Wang, Jing Xu, Xiaohan Wang, Menglin Bai, Guoxin Cai   +9 more
wiley   +1 more source

Esophageal Adenocarcinoma [PDF]

Clinical Gastroenterology and Hepatology, 2006
openaire   +2 more sources